ライフサイエンスコーパス: lower urinary tract

1 clusively expressed in the epithelium of the lower urinary tract).

2 ted reconstructive urological surgery on the lower urinary tract.

3 cord can promote functional recovery of the lower urinary tract.

4 yotonic discharges in skeletal muscle of the lower urinary tract.

5 omparable to transplantation into the normal lower urinary tract.

6 a role in functional neuroregulation of the lower urinary tract.

7 functions of respective target organs in the lower urinary tract.

8 ction, there were 8 infectious events of the lower urinary tract.

9 ted with complex pathology in the kidney and lower urinary tract.

10 s to deeper tissue and persist better in the lower urinary tract.

11 on, specifically, chemical irritation of the lower urinary tract.

12 h heterogeneous origins and functions of the lower urinary tract.

13 atients had one or more abnormalities of the lower urinary tract.

14 part of pretransplantation assessment of the lower urinary tract.

15 both molecules in neural development in the lower urinary tract.

16 neuromodulation, to treat pathologies of the lower urinary tract.

17 tic differences between TCC in the upper and lower urinary tracts.

18 to urologic diseases affecting the upper and lower urinary tracts.

19 performed on all children with dysfunctional lower urinary tracts.

20 ts were performed in 61 patients with normal lower urinary tracts.

21 tional cell carcinoma (TCC) of the upper and lower urinary tracts.

22 re more likely to have a foreign body in the lower urinary tract (48% versus 30% overall).

23 y increased 66%, suggesting sensitization of lower urinary tract afferents.

24 on regulates state-dependent reflexes in the lower urinary tract and contribute to our understanding

25 l to understanding the neural control of the lower urinary tract and how dysfunction arises in diseas

26 performed in 20 children with dysfunctional lower urinary tracts and 61 transplants were performed i

27 ry and digestive cancers and tumors from the lower urinary tract, and below 20% for the remaining TRC

28 ering the subjects of renal transplantation, lower urinary tract anomalies, and bladder reconstructio

29 Abnormalities of the lower urinary tract are common in children with unilater

30 When TCC of the upper and lower urinary tracts are compared, MSI-H is more frequen

31 ts to remain committed to rehabilitating the lower urinary tract avoiding palliative maneuvers and of

32 d to congenital anomalies of kidneys and the lower urinary tract (CAKUT) are poorly understood.

33 hat AS and EBS do not contribute to upper or lower urinary tract colonization by E. faecalis and that

34 The upper and lower urinary tract compartments form independently, con

35 activity and contributes to pathogenesis of lower urinary tract defects in human infants.

36 imarily a research tool in the evaluation of lower urinary tract disorders in the female; however, a

37 ways may reveal novel targets for therapy of lower urinary tract disorders such as overactive bladder

38 Lower urinary tract disorders such as overactive bladder

39 al calculi, lower urinary calculi, and other lower urinary tract disorders.

40 pefully lead to more effective treatments of lower urinary tract disorders.

41 be a target for pharmacological treatment of lower urinary tract disorders.

42 The cause of lower urinary tract dysfunction included posterior ureth

43 common neurological disease associated with lower urinary tract dysfunction is important for urologi

44 will involve pelvic organ prolapse (POP) and lower urinary tract dysfunction, are expected to reach e

45 en associated with undiagnosed and untreated lower urinary tract dysfunction, emphasizing the importa

46 toxin as a treatment modality for those with lower urinary tract dysfunction, especially for those wi

47 toxin has been investigated for treatment of lower urinary tract dysfunction.

48 ulinum toxin is awaiting approval for use in lower urinary tract dysfunction.

49 he vaginal wall, paraurethral pathology, and lower urinary tract dysfunction.

50 ract to evaluate the results of contemporary lower urinary tract evaluation and management on graft s

51 owever, 35% of patients with a dysfunctional lower urinary tract experienced urologic complications.

52 Prevention of lower urinary tract fistula requires improvement in the

53 Prevention of lower urinary tract fistula requires improvement in the

54 nimal-access procedures in reconstruction of lower urinary tract fistulas focusing on the bladder.

55 nimal-access procedures in reconstruction of lower urinary tract fistulas focusing on the bladder.

56 rious therapeutic approaches for normalizing lower urinary tract function after spinal cord injury.

57 complication rates, careful surveillance of lower urinary tract function by urodynamic evaluation is

58 bladder urothelium and their contribution to lower urinary tract function in the rat.

59 e complex impact of pelvic organ prolapse on lower urinary tract function is crucial to successful ma

60 e combined with the goal of restoring normal lower urinary tract function.

61 junction valve mechanism as well as aberrant lower urinary tract function.

62 sacral spinal nuclei involved in controlling lower urinary tract functions, including micturition, we

63 Foreign body in the lower urinary tract has a low incidence.

64 neurons innervating different regions of the lower urinary tract have different histochemical and ele

65 ctional cross-sensitization of the colon and lower urinary tract in a novel experimental model.

66 ccurrence of congenital abnormalities of the lower urinary tract in humans, the molecular, cellular a

67 erformed analysis of Y1015F mutant upper and lower urinary tracts in mice to delineate its molecular

68 Much of the lower urinary tract, including the bladder, is lined by

69 atory marker most predictive of upper versus lower urinary tract infection and renal scarring.

70 had pyuria and a diagnosis of a complicated lower-urinary-tract infection or pyelonephritis were ran

71 Lower urinary tract infections are among the most common

72 n the treatment of patients with complicated lower-urinary-tract infections or pyelonephritis.

73 se levofloxacin in patients with complicated lower-urinary-tract infections or pyelonephritis.

74 key for the successful management of female lower urinary tract injuries associated with lower abdom

75 importance of diagnosing and managing female lower urinary tract injuries, both of the bladder and th

76 juries are often associated with devastating lower urinary tract injuries.

77 nsion-free vaginal tape has a higher rate of lower urinary tract injury and voiding dysfunction when

78 nergic muscarinic system can be activated by lower urinary tract irritation to suppress visceral noci

79 KEY POINTS: The lower urinary tract is regulated by reflexes responsible

80 Renal transplantation into the abnormal lower urinary tract is successful but requires careful p

81 fferent pathways play in the function of the lower urinary tract is the focus of much current researc

82 ntracts smooth muscle cells within the human lower urinary tract (LUT) (bladder neck, prostate, and u

83 vestigated pudendal nerve innervation of the lower urinary tract (LUT) by employing anatomical (Sihle

84 Lower urinary tract (LUT) dysfunction is a common sequel

85 Chemical irritation of the lower urinary tract (LUT) induces c-fos expression in ne

86 tric burden, with many defects affecting the lower urinary tract (LUT), genital tubercle and associat

87 ociated protein 43 (GAP-43) were examined in lower urinary tract micturition reflex pathways in a chr

88 nd Eya1 are key regulators of both upper and lower urinary tract morphogenesis.

89 Fetal lower urinary tract obstruction (LUTO) is associated wit

90 uncommon but important cause of infravesical lower urinary tract obstruction that is more common in m

91 taking 5-ARIs for benign conditions such as lower urinary tract [obstructive] symptoms (LUTS) may be

92 he alpha 1-AR subtype prevalent in the human lower urinary tract(pA2 values: 8.8, 10.7, 9.3, and 9.9,

93 e superseded by prevention of the underlying lower urinary tract pathology.

94 derstand how sensory disruption manifests in lower urinary tract pathophysiology.

95 Despite these bothersome lower urinary tract problems in men, conservative treatm

96 laparoscopic surgery show that this type of lower urinary tract reconstruction can be carried out us

97 Neuroplasticity of lower urinary tract reflexes after SCI may be mediated b

98 ABSTRACT: Lower urinary tract reflexes are mediated by peripheral

99 mined (L1-L2 and L6-S1) that are involved in lower urinary tract reflexes.

100 omote clearance of infecting bacteria in the lower urinary tract represents a novel function for thes

101 Lower urinary tract response to acute obstruction and me

102 The lower urinary tract's virtually inevitable exposure to e

103 The prevalence of lower urinary tract storage disorders such as overactive

104 The main outcome was a change in a man's lower urinary tract symptom from baseline as measured by

105 Combination medical therapy improves lower urinary tract symptom in men with symptomatic beni

106 dergo surgery but scored 15-35 points on the lower urinary tract symptom questionnaire of the America

107 r who scored > or = 15 points of 35 on seven lower urinary tract symptom questions modified from the

108 From 1990 through 2000, lower urinary tract symptom severity was assessed by the

109 escribed medical therapy in the treatment of lower urinary tract symptom suggestive of benign prostat

110 ly 68% of the female nurses had at least one lower urinary tract symptom, nearly 50% had incontinence

111 eating OAB symptoms in children and men with lower urinary tract symptom.

112 management of neurogenic bladder and chronic lower urinary tract symptomatology, alpha antagonists wo

113 ing dysfunction, neurogenic bladder, chronic lower urinary tract symptomatology, idiopathic urethriti

114 Lower urinary tract symptoms (LUTS) are a common conditi

115 Lower urinary tract symptoms (LUTS) are a range of irrit

116 Lower urinary tract symptoms (LUTS) associated with beni

117 n prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) commonly affect olde

118 Worldwide, lower urinary tract symptoms (LUTS) due to benign prosta

119 miologic studies evaluating risk factors for lower urinary tract symptoms (LUTS) have focused on Whit

120 ies in men with benign prostatic hyperplasia/lower urinary tract symptoms (LUTS) in 2014.

121 jaculation, were investigated in relation to lower urinary tract symptoms (LUTS) in a large case-cont

122 inflammation may play a role in the cause of lower urinary tract symptoms (LUTS) in older men.

123 benign prostatic hyperplasia commonly cause lower urinary tract symptoms (LUTS) in the renal transpl

124 examined the association between obesity and lower urinary tract symptoms (LUTS) in the Third Nationa

125 d or acidic beverages as self-management for lower urinary tract symptoms (LUTS) is limited.

126 tatic hyperplasia (BPH) as the main cause of lower urinary tract symptoms (LUTS) may lead to acute ur

127 d women, there is an increasing incidence of lower urinary tract symptoms (LUTS) which are increasing

128 ncreases in benign prostatic enlargement and lower urinary tract symptoms (LUTS), and it is not clear

129 rrent evidence linking lifestyle factors and lower urinary tract symptoms (LUTS), and their relevance

130 or a role of inflammation in the etiology of lower urinary tract symptoms (LUTS), raising the possibi

131 se of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS), recent epidemiologi

132 Chronic lower urinary tract symptoms (LUTS), such as urgency and

133 the cause of clinically significant BPH with lower urinary tract symptoms (LUTS).

134 is prevalent in old men and often results in lower urinary tract symptoms (LUTS).

135 pment of benign prostatic hyperplasia and/or lower urinary tract symptoms (LUTS).

136 e and benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).

137 e varied pathophysiologic mechanisms causing lower urinary tract symptoms (LUTS).

138 ction therapy as an alternative treatment of lower urinary tract symptoms (LUTS).

139 ultifactorial problem that may include other lower urinary tract symptoms (LUTS).

140 matic benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).

141 may contribute to the development of BPH and lower urinary tract symptoms (LUTS).

142 H) effect symptomology in men suffering from lower urinary tract symptoms (LUTS).

143 How such therapies for lower urinary tract symptoms affect sexual function in m

144 e and behavioural interventions for men with lower urinary tract symptoms aim to allow the patient so

145 Lower urinary tract symptoms among female nurses should

146 study aimed to investigate the prevalence of lower urinary tract symptoms among female nurses, and th

147 From the literature, it is known that lower urinary tract symptoms and benign prostatic hyperp

148 Medical therapy for lower urinary tract symptoms and benign prostatic hyperp

149 the issue of combination medical therapy for lower urinary tract symptoms and benign prostatic hyperp

150 sy has surrounded the evaluation of men with lower urinary tract symptoms and benign prostatic obstru

151 Most of the data linking lower urinary tract symptoms and erectile dysfunction su

152 uria, have meant a shift in the way men with lower urinary tract symptoms are assessed and managed.

153 l history is a key step in assessing whether lower urinary tract symptoms are due to BPH or to some o

154 In men, lower urinary tract symptoms are most often attributed t

155 Male lower urinary tract symptoms are often attributed to ben

156 In women, lower urinary tract symptoms are often considered to res

157 y over the last decade and now most men with lower urinary tract symptoms are treated at some point w

158 Nearly all older men will experience lower urinary tract symptoms associated with benign pros

159 fruit extracts are widely used for treating lower urinary tract symptoms attributed to benign prosta

160 Lower urinary tract symptoms due to benign prostatic hyp

161 of diagnostic test accuracy among males with lower urinary tract symptoms due to bladder outlet obstr

162 aluation is the accurate characterization of lower urinary tract symptoms for the purposes of treatme

163 A substantial proportion of men with lower urinary tract symptoms have a combination of both

164 toileting behaviours exist among women, and lower urinary tract symptoms have a high prevalence and

165 Male patients with lower urinary tract symptoms have historically been mana

166 reatment of benign prostatic hyperplasia and lower urinary tract symptoms have yet to be performed.

167 mptoms and erectile dysfunction suggest that lower urinary tract symptoms impair the overall quality

168 We present a case report of AUV with lower urinary tract symptoms in a 6-year-old boy with co

169 tion of prostatic stents in the treatment of lower urinary tract symptoms in men secondary to benign

170 ignaling, and BSM remodeling associated with lower urinary tract symptoms in patients with BPH.

171 ore symptomatic among the cohort of men with lower urinary tract symptoms in the community.

172 ersies and developments in the evaluation of lower urinary tract symptoms in the female, and briefly

173 me guidance for the structured evaluation of lower urinary tract symptoms in the female, especially w

174 tial components of the initial evaluation of lower urinary tract symptoms in the female.

175 ed risks of benign prostatic hyperplasia and lower urinary tract symptoms include obesity, diabetes,

176 ides benefit for men with moderate to severe lower urinary tract symptoms including overactive bladde

177 The assessment of lower urinary tract symptoms is an essential component o

178 When further investigation of lower urinary tract symptoms is being considered, indivi

179 In both sexes, the etiology of lower urinary tract symptoms is multifactorial, and symp

180 ng study for the evaluation of patients with lower urinary tract symptoms is not suggested by America

181 Medical treatment of lower urinary tract symptoms is the mainstay of therapy

182 elationship between toileting behaviours and lower urinary tract symptoms is unclear.

183 Men with overactive bladder and other lower urinary tract symptoms may not respond to monother

184 is of bladder outlet obstruction in men with lower urinary tract symptoms may reduce the need for inv

185 ut only approximately two-thirds of men with lower urinary tract symptoms meet the accepted diagnosti

186 a saw palmetto fruit extract did not reduce lower urinary tract symptoms more than placebo.

187 1-0.52) and urinary symptoms (Bristol Female Lower Urinary Tract Symptoms Questionnaire; P=.002; effe

188 Alpha1-adrenergic antagonists relieve lower urinary tract symptoms related to benign prostatic

189 ltation on Incontinence Questionnaire-Female Lower Urinary Tract Symptoms scales were used to assess

190 havioural programme can significantly reduce lower urinary tract symptoms severity and decrease objec

191 Men presenting with lower urinary tract symptoms should undergo comprehensiv

192 Progressive neurological disease can cause lower urinary tract symptoms similar to those seen in bl

193 Men who have lower urinary tract symptoms that are consistent with be

194 th a diagnosis of BPH and moderate-to-severe lower urinary tract symptoms that were refractory to med

195 lly well tolerated therapy for patients with lower urinary tract symptoms thought to be associated wi

196 of standard benign prostatic hyperplasia and lower urinary tract symptoms treatment algorithms is pot

197 In men with lower urinary tract symptoms treatment may need to be di

198 However, lower urinary tract symptoms were not significantly asso

199 'Lower urinary tract symptoms' is a term that describes s

200 eing essential in the assessment of men with lower urinary tract symptoms, although there are no high

201 There was an improvement in lower urinary tract symptoms, assessed by International

202 qualitative and quantitative improvements in lower urinary tract symptoms, but also in offering a day

203 gnaling decreases BPH volume and can relieve lower urinary tract symptoms, but the mechanisms of andr

204 or treatment of storage symptoms in men with lower urinary tract symptoms, combinations of antimuscar

205 st-effective and accurate analysis of female lower urinary tract symptoms, existing technology must b

206 blockers can be useful for treatment of male lower urinary tract symptoms, including the overactive b

207 nic obstructive pulmonary disease, glaucoma, lower urinary tract symptoms, non-ST-segment elevation m

208 s the participants' toileting behaviours and lower urinary tract symptoms, respectively.

209 c hyperplasia, sexually transmitted disease, lower urinary tract symptoms, stress, and reduced sunlig

210 drawn from a general population of men with lower urinary tract symptoms, the calculations of incide

211 Among males with lower urinary tract symptoms, the likelihood ratios (LRs

212 In patients with lower urinary tract symptoms, the symptoms alone are not

213 etiologies may exist in the individual with lower urinary tract symptoms, treatment may fail as a re

214 ostate hyperplasia (BPH) is a major cause of lower urinary tract symptoms, with an increased volume o

215 nificantly associated with susceptibility to lower urinary tract symptoms.

216 reatment of benign prostatic hyperplasia and lower urinary tract symptoms.

217 association between toileting behaviours and lower urinary tract symptoms.

218 association between toileting behaviours and lower urinary tract symptoms.

219 evaluated anticholinergic drugs in men with lower urinary tract symptoms.

220 ness and safety of anticholinergics for male lower urinary tract symptoms.

221 trual period were negatively associated with lower urinary tract symptoms.

222 stress incontinence without increasing other lower urinary tract symptoms.

223 n delivery had a protective association with lower urinary tract symptoms.

224 gies (self-management) available to men with lower urinary tract symptoms.

225 mary aim of investigation for a patient with lower urinary tract symptoms.

226 ary evaluation of the female presenting with lower urinary tract symptoms.

227 reatment of benign prostatic hyperplasia and lower urinary tract symptoms.

228 ing to void) were positively associated with lower urinary tract symptoms.

229 ation and progression of clinically relevant lower urinary tract symptoms.

230 is one of the most common and bothersome of lower urinary tract symptoms.

231 recapitulate several clinical components of lower urinary tract symptoms.

232 tive as alpha1-adrenoceptor blockers in male lower urinary tract symptoms.

233 of bladder outlet obstruction in males with lower urinary tract symptoms.

234 perative to accurately define terminology of lower urinary tract symptoms.

235 urinary tract infection was associated with lower urinary tract symptoms.

236 ta regarding the incidence and prevalence of lower urinary tract symptoms/benign prostatic hyperplasi

237 cy of anticholinergic medication in men with lower urinary tract symptoms/benign prostatic hyperplasi

238 es of anticholinergic medication in men with lower urinary tract symptoms/benign prostatic hyperplasi

239 of drugs currently used for the treatment of lower urinary tract symptoms/overactive bladder syndrome

240 ncontrolled congestive heart failure, severe lower-urinary-tract symptoms, and erythrocytosis.

241 IBCs were associated with lower urinary tract syndrome (OR, 3.6; 95% CI, 1.1-11.8;

242 Overactive bladder is an important lower urinary tract syndrome that negatively affects the

243 icrosatellite instability occur in upper and lower urinary tract TCC, suggesting biologic differences

244 er and urethra in regulating reflexes in the lower urinary tract that depend on the state of the blad

245 act [the nephric duct (ND)] with that of the lower urinary tract (the cloaca).

246 le urethral sensory information plays in the lower urinary tract, the relationship between physiologi

247 sensory feedback plays in regulation of the lower urinary tract, there is little information about t

248 e alpha(1A) receptor being most prevalent in lower urinary tract tissue.

249 c renal transplantation into a dysfunctional lower urinary tract to evaluate the results of contempor

250 renergic receptors mediate both vascular and lower urinary tract tone, and alpha(1) receptor antagoni

251 ature is replete with studies involving male lower urinary tract trauma, however the diagnosis and ma

252 es in the diagnosis and management of female lower urinary tract trauma.

253 There were 23 upper and 61 lower urinary tract tumors confirmed in 15 and 32 patien

254 etection rate than the EP for both upper and lower urinary tract tumors, which suggests its possible

255 mooth muscle, and mesenchyme surrounding the lower urinary tract (via the Pax3-Cre transgene) resulte

256 A variety of fistulas occur involving the lower urinary tract with adjacent organs namely the vagi

257 A variety of fistulas occur involving the lower urinary tract with adjacent organs namely the vagi

258 ces in molecular embryology of the upper and lower urinary tract with an emphasis on clinical correla

259 c renal transplantation into a dysfunctional lower urinary tract yields outcomes comparable to transp